APA (7th ed.) Citation

S, H., JH, O., C, P., SH, B., IR, Y., HW, M., . . . JY, L. (2024). Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer. Korean journal of radiology, 25(2), 179. https://doi.org/10.3348/kjr.2023.0656

Chicago Style (17th ed.) Citation

S, Ha, O. JH, Park C, Boo SH, Yoo IR, Moon HW, Chi DY, and Lee JY. "Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer." Korean Journal of Radiology 25, no. 2 (2024): 179. https://doi.org/10.3348/kjr.2023.0656.

MLA (9th ed.) Citation

S, Ha, et al. "Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer." Korean Journal of Radiology, vol. 25, no. 2, 2024, p. 179, https://doi.org/10.3348/kjr.2023.0656.